DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Eric Linsley to speak at CED's Biotech Forum: "How Early is Too Early?" in RTP, NC
News | 04. 28. 2008
